Preliminary findings from our laboratory suggest that silencing of SNAT3 neither reduces total glutamine uptake nor significantly alters the proliferation of human GBM T98G cells, which, in contrast to the primary cells derived from patients with GBM, express considerable amounts of SNAT3 transcript (unpublished data). This evidence concerns the gene SLC38A3 and glioblastoma.